lutetium has been researched along with Adverse Drug Event in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Argiroffi, G; Baccini, M; Centonze, G; Fuoco, V; Garanzini, EM; Gherardini, L; Kirienko, M; Maccauro, M; Milione, M; Prinzi, N; Pusceddu, S; Scalorbi, F; Seregni, E | 1 |
1 other study(ies) available for lutetium and Adverse Drug Event
Article | Year |
---|---|
Application of FLIC model to predict adverse events onset in neuroendocrine tumors treated with PRRT.
Topics: Aged; Antineoplastic Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lutetium; Male; Middle Aged; Models, Theoretical; Neoplasm Grading; Neoplasm Staging; Neuroendocrine Tumors; Prognosis; Radioisotopes; Radiopharmaceuticals; Renal Insufficiency | 2021 |